TY - JOUR
T1 - The European Renal Association - European Dialysis and Transplant Association Registry Annual Report 2014: a summary
AU - Pippias, Maria
AU - Kramer, Anneke
AU - Noordzij, Marlies
AU - Afentakis, Nikolaos
AU - Alonso de la Torre, Ramón
AU - Ambühl, Patrice M.
AU - Aparicio Madre, Manuel I.
AU - Arribas Monzón, Felipe
AU - Åsberg, Anders
AU - Bonthuis, Marjolein
AU - Bouzas Caamaño, Encarnación
AU - Bubic, Ivan
AU - Caskey, Fergus J.
AU - Castro de la Nuez, Pablo
AU - Cernevskis, Harijs
AU - de Los Ángeles Garcia Bazaga, Maria
AU - des Grottes, Jean-Marin
AU - Fernández González, Raquel
AU - Ferrer-Alamar, Manuel
AU - Finne, Patrik
AU - Garneata, Liliana
AU - Golan, Eliezer
AU - Heaf, James G.
AU - Hemmelder, Marc H.
AU - Idrizi, Alma
AU - Ioannou, Kyriakos
AU - Jarraya, Faical
AU - Kantaria, Nino
AU - Kolesnyk, Mykola
AU - Kramar, Reinhard
AU - Lassalle, Mathilde
AU - Lezaic, Visnja V.
AU - Lopot, Frantisek
AU - Macario, Fernando
AU - Magaz, Ángela
AU - Martín de Francisco, Angel L.
AU - Martín Escobar, Eduardo
AU - Martínez Castelao, Alberto
AU - Metcalfe, Wendy
AU - Moreno Alia, Inmaculada
AU - Nordio, Maurizio
AU - Ots-Rosenberg, Mai
AU - Palsson, Runolfur
AU - Ratkovic, Marina
AU - Resic, Halima
AU - Rutkowski, Boleslaw
AU - Santiuste de Pablos, Carmen
AU - Seyahi, Nurhan
AU - Fernanda Slon Roblero, María
AU - Spustova, Viera
AU - Stas, Koenraad J. F.
AU - Stendahl, María E.
AU - Stojceva-Taneva, Olivera
AU - Vazelov, Evgueniy
AU - Ziginskiene, Edita
AU - Massy, Ziad
AU - Jager, Kitty J.
AU - Stel, Vianda S.
PY - 2017
Y1 - 2017
N2 - Background: This article summarizes the European Renal Association - European Dialysis and Transplant Association Registry's 2014 annual report. It describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2014 within 35 countries. Methods: In 2016, the ERA-EDTA Registry received data on patients who in 2014 where undergoing RRT for ESRD, from 51 national or regional renal registries. Thirty-two registries provided individual patient level data and 19 provided aggregated patient level data. The incidence, prevalence and survival probabilities of these patients were determined. Results: In 2014, 70 953 individuals commenced RRT for ESRD, equating to an overall unadjusted incidence rate of 133 per million population (pmp). The incidence ranged by 10-fold; from 23 pmp in the Ukraine to 237 pmp in Portugal. Of the patients commencing RRT, almost two-thirds were men, over half were aged ≥65 years and a quarter had diabetes mellitus as their primary renal diagnosis. By day 91 of commencing RRT, 81% of patients were receiving haemodialysis. On 31 December 2014, 490 743 individuals were receiving RRT for ESRD, equating to an unadjusted prevalence of 924 pmp. This ranged throughout Europe by more than 10-fold, from 157 pmp in the Ukraine to 1794 pmp in Portugal. In 2014, 19 406 kidney transplantations were performed, equating to an overall unadjusted transplant rate of 36 pmp. Again this varied considerably throughout Europe. For patients commencing RRT during 2005-09, the 5-year-adjusted patient survival probabilities on all RRT modalities was 63.3% (95% confidence interval 63.0-63.6). The expected remaining lifetime of a 20- to 24-year-old patient with ESRD receiving dialysis or living with a kidney transplant was 21.9 and 44.0 years, respectively. This was substantially lower than the 61.8 years of expected remaining lifetime of a 20-year-old patient without ESRD
AB - Background: This article summarizes the European Renal Association - European Dialysis and Transplant Association Registry's 2014 annual report. It describes the epidemiology of renal replacement therapy (RRT) for end-stage renal disease (ESRD) in 2014 within 35 countries. Methods: In 2016, the ERA-EDTA Registry received data on patients who in 2014 where undergoing RRT for ESRD, from 51 national or regional renal registries. Thirty-two registries provided individual patient level data and 19 provided aggregated patient level data. The incidence, prevalence and survival probabilities of these patients were determined. Results: In 2014, 70 953 individuals commenced RRT for ESRD, equating to an overall unadjusted incidence rate of 133 per million population (pmp). The incidence ranged by 10-fold; from 23 pmp in the Ukraine to 237 pmp in Portugal. Of the patients commencing RRT, almost two-thirds were men, over half were aged ≥65 years and a quarter had diabetes mellitus as their primary renal diagnosis. By day 91 of commencing RRT, 81% of patients were receiving haemodialysis. On 31 December 2014, 490 743 individuals were receiving RRT for ESRD, equating to an unadjusted prevalence of 924 pmp. This ranged throughout Europe by more than 10-fold, from 157 pmp in the Ukraine to 1794 pmp in Portugal. In 2014, 19 406 kidney transplantations were performed, equating to an overall unadjusted transplant rate of 36 pmp. Again this varied considerably throughout Europe. For patients commencing RRT during 2005-09, the 5-year-adjusted patient survival probabilities on all RRT modalities was 63.3% (95% confidence interval 63.0-63.6). The expected remaining lifetime of a 20- to 24-year-old patient with ESRD receiving dialysis or living with a kidney transplant was 21.9 and 44.0 years, respectively. This was substantially lower than the 61.8 years of expected remaining lifetime of a 20-year-old patient without ESRD
U2 - https://doi.org/10.1093/ckj/sfw135
DO - https://doi.org/10.1093/ckj/sfw135
M3 - Article
C2 - 28584624
SN - 2048-8513
VL - 10
SP - 154
EP - 169
JO - Clinical Kidney Journal
JF - Clinical Kidney Journal
IS - 2
ER -